Gut bacteria clues could unlock liver disease mysteries
NCT ID NCT07455175
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how changes in gut bacteria, driven by a substance called lactate, might be linked to the worsening of liver cirrhosis. Researchers will follow 200 people, including healthy volunteers and cirrhosis patients, to measure lactate levels in blood, stool, and tissue. The goal is to better understand the disease and find new ways to track its progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify new ways to track or slow liver cirrhosis progression by targeting gut bacteria.
- What could go wrong
- This is an early observational study, not a treatment trial. It may find no clear link, and results may not lead to direct patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?